Dysferlin quantification in monocytes for rapid screening for dysferlinopathies

Laura Sánchez-Chapul, Miguel Del Ángel-Muñoz, Luis Ruano-Calderón, Alexandra Luna-Angulo, Ramón Coral-Vázquez, Óscar Hernández-Hernández, Jonathan J. Magaña, Saúl R. León-Hernández, Rosa E. Escobar-Cedillo, Steven Vargas

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Introduction: In this study, we determined normal levels of dysferlin expression in CD14+ monocytes by flow cytometry (FC) as a screening tool for dysferlinopathies. Methods: Monocytes from 183 healthy individuals and 29 patients were immunolabeled, run on an FACScalibur flow cytometer, and analyzed by FlowJo software. Results: The relative quantity of dysferlin was expressed as mean fluorescence intensity (MFI). Performance of this diagnostic test was assessed by calculating likelihood ratios at different MFI cut-off points, which allowed definition of 4 disease classification groups in a simplified algorithm. Conclusion: The MFI value may differentiate patients with dysferlinopathy from healthy individuals; it may be a useful marker for screening purposes. Muscle Nerve 54: 1064–1071, 2016.

Original languageEnglish
Pages (from-to)1064-1071
Number of pages8
JournalMuscle and Nerve
Volume54
Issue number6
DOIs
StatePublished - 1 Dec 2016

Keywords

  • dysferlin
  • dysferlinopathies
  • flow cytometry
  • monocytes
  • muscular dystrophies

Fingerprint

Dive into the research topics of 'Dysferlin quantification in monocytes for rapid screening for dysferlinopathies'. Together they form a unique fingerprint.

Cite this